久祺股份(300994.SZ):擬將“年產100萬輛自行車及100萬輛電動助力車智能製造項目”結項 並將節餘募資永久補流
格隆匯6月27日丨久祺股份(300994.SZ)公佈,公司於2025年6月27日召開了第三屆董事會第二次會議、第三屆監事會第二次會議,分別審議通過了《關於部分募投項目結項並將節餘募集資金永久補充流動資金的議案》,同意公司將首次公開發行股票募投項目“年產100萬輛自行車及100萬輛電動助力車智能製造項目”結項,公司擬將項目節餘募集資金3,125.67萬元《(以資金轉出當日銀行結息後實際金額爲準)用於永久補充流動資金,用於公司日常生產經營及業務發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.